rotation.to
Following this device: dark.
Free account
rotation.to
Sign in / Request free access
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Thomas Jeffrey Hargroves

Director

Company insider

Files Form 4 as: Director, Cingulate.

Every Form 4 they filed

In numbers

Trades disclosed
12
Buys
2
Sells
0
Bought
$981K
Sold
$0
Companies
1
Companies where not an officer
1
First trade
7 Dec 2021
Last trade
16 Jul 2026
Last filed
20 Jul 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
CING CingulateDirector · Biotechnology · last 16 Jul 20262 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
01Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
16 Jul 2026filed 20 Jul 2026CING Cingulateoption or derivative · BiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
16 Jul 2026filed 20 Jul 2026CING Cingulateoption or derivative · BiotechnologySEC FORM 4 Code A—20,000 at $0.00filing
9 Mar 2026filed 8 Jun 2026CING Cingulateoption or derivative · BiotechnologySEC FORM 4 Code A—15,000 at $0.00filing
9 Mar 2026filed 8 Jun 2026CING Cingulateoption or derivative · BiotechnologySEC FORM 4 Code A—15,000 at $0.00filing
13 Feb 2026filed 8 Jun 2026CING CingulateBiotechnologySEC FORM 4 Bought$490K97,276 at $5.04filing
13 Feb 2026filed 8 Jun 2026CING Cingulateoption or derivative · BiotechnologySEC FORM 4 Code P$7,78277,821 at $0.10filing
13 Feb 2026filed 8 Jun 2026CING Cingulateoption or derivative · BiotechnologySEC FORM 4 Code P$7,78277,821 at $0.10filing
13 Feb 2026filed 8 Jun 2026CING CingulateBiotechnologySEC FORM 4 Bought$490K97,276 at $5.04filing
25 Feb 2022filed 1 Mar 2022CING Cingulateoption or derivative · BiotechnologySEC FORM 4 Code A—9,000 at $0.00filing
10 Dec 2021filed 14 Dec 2021CING Cingulateoption or derivative · BiotechnologySEC FORM 4 Code A—8,300filing
10 Dec 2021filed 14 Dec 2021CING CingulateBiotechnologySEC FORM 4 Bought—8,300filing
7 Dec 2021filed 9 Dec 2021CING Cingulateoption or derivative · BiotechnologySEC FORM 4 Code A—8,983 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care2

Buys in green, sells in red, by the company’s sector.

Related people

Raul R. SilvaEVP and CSO · EVP and CSO at Cingulate, filing Form 4 there in the last year
Peter J. WerthDirector · Director at Cingulate, filing Form 4 there in the last year
Jennifer L. CallahanEVP and CFO · EVP and CFO at Cingulate, filing Form 4 there in the last year
Matthew BramsEVP and Chief Medical Officer · EVP and Chief Medical Officer at Cingulate, filing Form 4 there in the last year
Bryan Jay LawrenceDirector · Director at Cingulate, filing Form 4 there in the last year